Literature DB >> 15802334

Lung function, smoking and mortality in a 26-year follow-up of healthy middle-aged males.

K Stavem1, E Aaser, L Sandvik, J V Bjørnholt, G Erikssen, E Thaulow, J Erikssen.   

Abstract

Lung function has been associated with mortality after adjusting for other risk factors; however, few studies have adjusted for physical fitness and reported separate analyses according to smoking status. In 1972-1975, spirometry, clinical and physiological parameters were recorded in 1,623 apparently healthy males aged 40-59 yrs. After 26 yrs of follow-up, the current authors investigated the association between baseline lung function and mortality, adjusting for smoking, physical fitness and other potential factors. By 2000, 615 individuals (38%) had died, with 308 (50%) of these deaths from cardiovascular (CV) causes. Forced expiratory volume in one second was a predictor of all-cause mortality (risk ratio (RR) 1.10 per reduction of 10%) after adjusting for smoking, physical fitness, age, systolic blood pressure, body mass index and serum cholesterol. The corresponding multivariate RR was 1.07 for CV causes and 1.34 for respiratory death. In conclusion, in stratified analyses among current and former smokers, forced expiratory volume in one second % predicted was a strong independent predictor of all-cause mortality and respiratory death among current smokers. Forced expiratory volume in one second % predicted was not associated with mortality among never-smokers.

Entities:  

Mesh:

Year:  2005        PMID: 15802334     DOI: 10.1183/09031936.05.00008504

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  33 in total

Review 1.  Accelerating research on biological aging and mental health: Current challenges and future directions.

Authors:  Laura K M Han; Josine E Verhoeven; Audrey R Tyrka; Brenda W J H Penninx; Owen M Wolkowitz; Kristoffer N T Månsson; Daniel Lindqvist; Marco P Boks; Dóra Révész; Synthia H Mellon; Martin Picard
Journal:  Psychoneuroendocrinology       Date:  2019-04-05       Impact factor: 4.905

2.  Markers of chronic obstructive pulmonary disease are associated with mortality in people living with HIV.

Authors:  Matthew Triplette; Amy Justice; Engi F Attia; Janet Tate; Sheldon T Brown; Matthew Bidwell Goetz; Joon W Kim; Maria C Rodriguez-Barradas; Guy W Soo Hoo; Cherry Wongtrakool; Kathleen Akgün; Kristina Crothers
Journal:  AIDS       Date:  2018-02-20       Impact factor: 4.177

3.  Respiratory symptoms and 30 year mortality from obstructive lung disease and pneumonia.

Authors:  A Frostad; V Soyseth; T Haldorsen; A Andersen; A Gulsvik
Journal:  Thorax       Date:  2006-06-29       Impact factor: 9.139

4.  Pulmonary function and CT biomarkers as risk factors for cardiovascular events in male lung cancer screening participants: the NELSON study.

Authors:  Richard A P Takx; Rozemarijn Vliegenthart; Firdaus A A Mohamed Hoesein; Ivana Išgum; Harry J de Koning; Willem P Th M Mali; Carlijn M van der Aalst; Pieter Zanen; Jan-Willem J Lammers; Harry J M Groen; Eva M van Rikxoort; Michael Schmidt; Bram van Ginneken; Matthijs Oudkerk; Tim Leiner; Pim A de Jong
Journal:  Eur Radiol       Date:  2014-09-03       Impact factor: 5.315

5.  Environmental exposures and systemic hypertension are risk factors for decline in lung function.

Authors:  Catherine H Miele; Matthew R Grigsby; Trishul Siddharthan; Robert H Gilman; J Jaime Miranda; Antonio Bernabe-Ortiz; Robert A Wise; William Checkley
Journal:  Thorax       Date:  2018-07-30       Impact factor: 9.139

6.  Age is a predictor of a small decrease in lung function in children with sickle cell anemia.

Authors:  Shaina M Willen; Robyn Cohen; Mark Rodeghier; Fenella Kirkham; Susan S Redline; Carol Rosen; Jane Kirkby; Michael R DeBaun
Journal:  Am J Hematol       Date:  2018-01-25       Impact factor: 10.047

7.  Rapid lung function decline in smokers is a risk factor for COPD and is attenuated by angiotensin-converting enzyme inhibitor use.

Authors:  Hans Petersen; Akshay Sood; Paula M Meek; Xian Shen; Yan Cheng; Steven A Belinsky; Caroline A Owen; George Washko; Victor Pinto-Plata; Emer Kelly; Bartolome Celli; Yohannes Tesfaigzi
Journal:  Chest       Date:  2014-04       Impact factor: 9.410

8.  Chronic obstructive pulmonary disease: an update of treatment related to frequently associated comorbidities.

Authors:  Nicola J Sinden; Robert A Stockley
Journal:  Ther Adv Chronic Dis       Date:  2010-03       Impact factor: 5.091

9.  Gender differences in the effect of occupational endotoxin exposure on impaired lung function and death: the Shanghai Textile Worker Study.

Authors:  Peggy S Lai; Jing-Qing Hang; Feng-Ying Zhang; Xinyi Lin; Bu-Yong Zheng; Hei-Lian Dai; Li Su; Tianxi Cai; David C Christiani
Journal:  Occup Environ Med       Date:  2013-12-02       Impact factor: 4.402

10.  Chronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidity.

Authors:  Joseph Finkelstein; Eunme Cha; Steven M Scharf
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-09-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.